BioLife Solutions (BLFS) Tops Q1 EPS by 13c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
QEPC, NTRP, LOOP, More
Revenue Growth %: +3.9%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
QEPC, NTRP, LOOP, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.22), $0.13 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $31.73 million versus the consensus estimate of $27.42 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIR Global sets first-ever dividend, $100M buyback amid business, cash strength
- Independent Bank (INDB) Tops Q3 EPS by 5c
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
